Tuesday, May 17, 2022 9:53:51 PM
Sorry, the CLNV Management does not work off hunches from social media boards. They work of factual data and comparisons between products CLNV picked the best partner for the Pyrolysis Systems based on technical data that provided the solutions that the customer wanted. Sorry if GGII wasnt selected that should tell you why their stock is only .0024/share.
Recent CLNV News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 04:01:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:31:49 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/15/2023 09:57:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:03:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:54:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:59:55 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/26/2023 04:15:31 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/20/2023 08:15:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/15/2023 09:29:32 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 08/31/2023 01:59:28 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:23:35 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 07:48:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 07:14:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 07:39:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 05:27:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM